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Abstract  Background: Central 
diabetes insipidus (CDI) is rare in 
children. About 30 - 50% of cases 
are idiopathic. Early and accurate 
diagnosis are crucial for safe and 
effective treatment. This is the 
first report of Central diabetes 
insipidus in a child in Nigeria. 
Case report: We report a case of 
central diabetes insipidus in a 
female toddler who presented at 
the University of Port Harcourt 
Teaching Hospital with polydipsia 
and polyuria with a urine specific 
gravity of 1.000 and normal blood 
sugar. The diagnosis of CDI was 
confirmed by her inability to   
concentrate urine after a water 
deprivation test followed by an in-
crease in urine osmolality from 
59mOsm/kg to 158mOsm/kg and 
serum osmolality from 286mOsm/kg 
to 321Osm/kg following intravenous 
administration of desmopressin. The 
patient responded well to oral des-
mopressin. 
Conclusion: Central diabetes in-
sipidus occurs in Nigerian children 
and responds to oral desmopressin. 
We recommended high index of sus-
picion in children with polyuria and 
polydipsia.  
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Introduction 
 
Central diabetes insipidus (CDI)is a heteregenous cndi-
tion characterized by polyuria and polydipsia due to 
deficiency of arginine vasopressin (AVP).1-3 It is a  
rareendocrine disorder in children and results from the 
destruction or degeneration of AVPsecreting neurons in 
the supraoptic and paraventricular nuclei of the hypo-
thalamus or from impairment to the release or transport 
of AVP.  CDI may be idopathic, inherited or acquired. 
Approximately 30 to 50% of cases of CDI are consid-
ered idiopathic. Congenital or inherited forms which are 
very rare and may be due to genetic defects in the syn-
thesis of AVP that are inherited as autosomal dominant 
or X-linked recessive traits. Acquired or secondary 
causes include head trauma resulting from surgery or 
accident; central nervous tumors such as germinoma and 
craniopharyngioma; Langerhans’cell histiocytosis; cen-
tral nervous infections such as tuberculosis, meningitis; 
autoimmune disorders andvascular lesions such as aneu-
rysms and arteriovenous malformations.1-3 
 
Deficiency of AVP causes excessive and uncontrolled 
loss of water from the kidneys with resultant hypos-
thenuria, inordinate thirst and an increase in serum  
osmolality. The complications which include dehydra-
tion, hypernatraemia and seizures are usually fatal.4 
Therefore, early recognition and accurate diagnosis are-
crucial to limit morbidity and mortality. 
 
In Nigeria, Diabetes insipidus has been reported in 
adults following burns andsurgery.5To the best of the 
knowledge of the authors, no of case CDI has been r-
ported in children in Nigeria. We therefore report the 
first case of CDI in a toddler in our centre in order to 





C.N was a two year eight month old female referred 
from Federal Medical Centre, Yenegoa, Bayelsa State to 
the Children’s Emergency Room of the University of 
Port Harcourt Teaching Hospital (UPTH), Port  
Harcourt, Rivers State with complaints of excessive  
ingestion of water and urination of two months duration. 
Onset of symptoms was gradual with excessive inges-
tion of water increasing from about 500mililitre (ml) per 
day to  9- 10Litres (L) per day. She wakes up about 6-7 
times at night to drink water and this usually disturbs 
sleep. There was also increase in both frequency of uri-
nation and volume of urine voided; from1- 2 times to 10
-15 times during the day and from nil to 5-7 times at 
night. There was no history of body swelling, poly-
phagia, fever, head trauma, chronic cough, weight loss, 
seizures, use of nephrotoxic drugs or surgery prior to 
onset of symptoms. She was initially treated in a private 
clinic for malaria but with persistence of symptoms, she 
was taken to the referral hospital. Random blood sugar 
(RBS) done was 6.4mmol/L; urinalysis showed a low 
specific gravity (S.G) of 1.005. She was subsequently 
referred to UPTH with a presumed diagnosis of Diabetes 
insipidus (DI). Pregnancy, birth, neonatal and develop-
mental histories were essentially uneventful. She is the 
(      )
second of three children (all females) in a monogamous 
family. Mother is a 26 year old nurse and father is a 38 
year old business man with tertiary education. There was 
no history of similar symptoms in the parents, siblings 
or close relatives. 
 
On examination, she was conscious, calm, a febrile, well 
hydrated with moist buccal mucosa with no loss of skin 
tugor. Her weight was 15kg (115% of expected); heigt 
was 96cm (108% of expected). Her radial pulse was 
regular, full volume with a rate of 110beats per minute; 
blood pressure was 80/50mmHg (which was normal). 
Examination of the systems were essentially normal. A 
bedside dipstick urinalysis showed a colourless urine 
with a pH 6 and a very low S.G of 1.000 without glyco-
suria or proteinuria. Random blood sugar was 5.4mmol/
L (which was within normal range). An initial diagnosis 
of Diabetes insipidus was made. 
 
Serum electrolytes, urea and creatinine done on admis-
sion showed Sodium of 139mmol/L (normal range: 128 
- 142mmo/L); Potassium of 3.7mmol/L(normal range: 
3.4 - 4.8mmol/L); Bicarbonate of 22mmol/L (normal 
range: 24 - 30mmol/L); Urea of 2.2mmol/L (normal 
range: 2.4 - 6mmol/L) and Creatinine of 40µmol/L 
(normal range: 60 - 120µmol/L). Serum Osmolality 
[calculated from the formula6:  serum osmolality in 
mOsm/Kg = 2 × serum Sodium (mmo/L) + serum Glu-
cose (mmol/L) + serum Urea (mmol/L)] was 286mOsm/
kg. Serum calcium was 2.2mmol/L (normal range: 2.1 - 
2.6mmol/L). Full blood count which was within normal 
limits showed a packed cell volume of  31%; white 
blood cell of 6.2 × 109; neutrophils of 44%; lymphocyte 
56%; normal electrolyte sedimentation rate of 8mm/
hour. Blood film was essentially normal. Urine micros-
copy and culture showed heavy growth of E.coli sensi-
tive to nitrofurantoin and ceftazidine. 
Abdominal ultrasonography was normal showed that 
both kidneys were normal in size, position and echo-
genicity with good corticomedulary differentiation. 
There were no renal cysts or calculi. Radiograph of the 
skull showed normal bones and sella turcica; there was
no abnormal lucency or calcification. Assay for serum 
levels of AVP, Magnetic Resonance Imaging (MRI) and 
genetic studies were not done due to unavailability of 
such studies in our centre and environs. 
 
A water deprivation test was done over six hours. She
was weighed two hourly throughout the duration of the
test. There was no change in the weight pre and post 
water deprivation at 15Kg. Total volume of urine voided 
was 2,030mls (11ml/kg/hour) and the urine S.G re-
mained 1.000.Serum and urine samples for osmolality 
analysed at Pathcare laboratory showed that  urine os-
molality was 59 mOsm/Kg and serum osmolality was 
286mOsm/Kg. Intravenous desmopressin 2µg was given 
after the water deprivation test. Total volume of urine 
voided 2hours later was 125ml (2.6mls/kg/hour); urine 
SG increased to 1.010. There was increase in the urin
osmolality and serum osmolality to 158mOsm/kg and 
321Osm/kg  
respectively. The diagnosis of CDI in the index patient 
was made based on the symptoms of excessive water 
intake and urination, craving for water; persistent hypos-
thenuria, passage of large volume (11ml/Kg/hour) of 
urine despite  lack of oral input during the water d pri-
vation test, absence of urine concentration on water dep-
rivation followed by an increase in urine and  serum 
osmolalilty following the administration of desmo-
pressin. The urinary tract infection was treated with oral 
nitrofurantoin 25mg three times a day for 10 days. 
 
She was allowed free access to water and received des-
mopressin tablets (25mg twice a day initially then in-
creased to 50mg twice a day due to poor response. There 
was reduction of urine volume to 2.5L during the day 
and nil at night noticed on the second day of commence-
ment of desmopressin. Urine specific gravity also in-
creased ranging from 1.010 - 1.016 throughout the dura-
tion of hospitalisation. She was discharged after three 
weeks of admission on oral desmopressin. She came for 
follow up once one week after discharge. On follow up 
visit, polyuria and polydipsia had reduced; urine fr -
quency had reduced to 1 -2 times during the day and nil 
to once at night. Telephone conversations with the 
mother revealed that child is alive, still on desmo-
pressin; polyuria and polydipsia had greatly subsided. 
 
Table 1: Biochemical parameters before and after water 
deprivation test and desmopressin administration in the 








CDI is a form of polyuric polydipsic disorder which 
occurs mainly due to lesions of the neurohypophysis or 
the hypothalamuc median eminence resulting in defi-
cient synthesis and or release of AVP.7The clinical 
manifestation of CDI is variable, depending on the ex-
tent of neuronal destruction. Usually 80 to 90% of the
magno- cellular neurones in the hypothalamus need to 
be damaged before symptoms of DI arise.7Polyuria and 
polydipsia which are the essential features4 were present 
in the index patient. The onset of symptoms is usually 
abrupt or sudden in CDI due to head trauma or neurosur-
gical interventions and gradual in other forms of nn-
trauma conditions.8However, in some cases, CDI may 
be a chronic complication of head injury or subarach-
noid haemorrhage.9In the index patient, the onset of 





























trauma or surgery. The age at presentation also varies 
depending on the underlying aetiology.4,8 Severe neona-
tal forms are rarely described in children. In contras , 
hereditary Nephrogenic DI manifests in early infancy, 
often before the age of 1 week.4,8The familial autosomal 
recessive formmay manifest at infancy while that due to 
developmental defects of midline brain structure may 
present early.8,10Symptoms in the index patient devel-
oped at the age of 2 years and 6 months. Maghnie at 
al1in Italy in a study of children with CDI reported that 
the mean age at presentation were 6.4 years, 7.5 years 
and 1.4 years for the idiopathic, secondary form due to 
intracranial tumor and the familial forms respectively. 
 
The clinical manifestations of CDI are due to defici n y 
of AVP and disturbance in water metabolism. Excessive 
loss of water from the kidney (polyuria) will result in 
dehydration, hypernatraemia and a corresponding in-
crease in serum osmolality.4However, in ambulatory 
patients with intact thirst mechanism and free access to 
water, hypernatraemia and dehydration do not oc-
cur.11This may explain the absence of dehydration, nor-
mal serum sodium levels and serum osmolality in the 
index patient. 
 
The water deprivation test (Miller-Moses test) together 
with the intravenous administration of desmopressin are 
useful in the confirmation of  the diagnosis of CDI and 
also to distinguish between Nephrogenic DI and Prima y 
polydipsia.4In CDI, urine osmolality is usually less than 
300 mOsm/kg after dehydrationand greater than 750 
mOsm/kg following desmopressin administration.12I  
the index patient,  the diagnosis of CDI was confirmed 
based on the absence of urine concentration on water 
deprivation followed by an increase urine and serum 
osmolalilty following the administration of desmo-
pressin. Although, the urine osmolality was less than 
750 mOsm/kg after desmopressin administration, there 
was more than a double-fold increase in urine osmola-
lilty from  59mOsm/kg to 158mOsm/kg. Similar finding 
has been reported in children by Wong et al13 in Hong 
Kong where the urine osmolality was less than 750 
mOsm/kg post desmopressin administrationin all ten 
children with CDI. A possible explanation to this is that 
in long standing polyuria there is partial washout f he 
medullary interstitial gradient and downward regulation 
of AVP release leading to defect in urinary concentra-
tion.12 
 
The urinary concentration test is an indirect measure of 
AVP activity. The combination of the water deprivaton 
test and  direct AVP  determination would allow the 
diagnosis of more than 95% of all cases of CDI  cor-
rectly.14 However, AVP assay has failed to be a diagnos-
tic reference standard to date due to its methodological 
limitations of a very short half life of 10 -30 minutes, 
high pre analytical instability and high turnaround time 
in most laboratories.15 More recently plasma copeptin 
levels have been studied as a surrogate marker of AVP 
in the differential diagnosis of DI.16Copeptin, the  
C-terminal part of the AVP precursor, co-secreted with 
AVP is much easier to measure. It was demonstrated 
that plasma copeptin is a valuable surrogate of AVP 
release in patients with the DI, exhibiting a promising 
diagnostic potential.16 
 
MRI of the pituitary gland has emerged as another us -
ful addition to the biochemical tests in the diagnosis of 
CDI. The physiological bright spot in the posterior pitui-
tary o the sella turcica is persistent in patients with Pri-
mary polydipsia and is absent inCDI.17However, indi-
vidual cases of CDI with persistent pituitary bright spot 
have been reported  most likely due to an early stage of 
the disease.18 Also,  anage-related absence of the signal 
has been described in up to 20% of normal subjects.19 
Conversely in NDI, the bright spot is present in some 
patients and absent in others.20 Consequently, the role of 
MRI as a diagnostic test in patients with DI remains to 
be clarified. It has been suggested that MRI is a more 
useful tool for ruling out than for ruling in a diagnosis of 
CDI.21 A very similar conclusion also seems to apply to 
measurements of thepituitary stalk, whose enlargement 
beyond 2–3 mm has been considered to be pathologica, 
but not necessarily specific for idiopathic CDI.22MRI 
was not done in the index patient due unavailability of 
the services in the hospital. 
 
The therapeutic goals of treatment of CDI are primaily 
to reduce polyuria and decrease thirst so that the child is 
able to grow adequately and maintain a normal life style. 
Free access to water will facilitate maintenance of tonic-
ity if the thirst mechanism is intact.8 The index patient 
was allowed free access to water. Excess fluid intake in 
the long term may lead to hydronephrosis and hy-
droureters.23 The index patient did not have clinical or 
radiologic evidence of hydronephrosis or hydroureters. 
Desmopressin (1-deamino-8-D-arginine vasopressin, 
dDAVP), an analogue of vasopressin, is the current drug 
of choice for long-term therapy of CDI.4 It increases the 
cellular permeability of the collecting ducts resulting in 
an increase in water reabsorption and therefore mini-
mises water excretion. The index patient responded well 





CDI would occur in Nigerian children and responds well 
to oral desmopressin. We recommend a high index of 
suspicion in children with polyuria and polydipsia as 
early recognition and accurate diagnosis is crucial to 
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